Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice

Journal of the American Society of Nephrology

Volumn 18, Issue 9, 2007, Pages 2473-2485

  Ka, Shuk Man ^a   Sytwu, Huey Kang ^b   Chang, Deh Ming ^a   Hsieh, Shie Liang ^b   Tsai, Pei Yi ^b   Chen, Ann ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; DECOY RECEPTOR 3; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE CRESCENTIC GLOMERULONEPHRITIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; GENE DELIVERY SYSTEM; GENE THERAPY; GLOMERULONEPHRITIS; HYDRODYNAMICS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 34548505481     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006111242     Document Type: Article

References (50)

1. Abbas AK: Disease of immunity. In: Robbins and Cotran Pathologic Basis of Disease, 7th Ed., edited by Kumar V, Abbas AK, Fausto N, Philadelphia, Saunders, 2005, pp 227
2. Hoffman RW: T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol 113: 4-13, 2004
3. Nagy G, Koncz A, Perl A: T- and B-cell abnormalities in systemic lupus erythematosus. Crit Rev Immunol 25: 123-140, 2005
4. Mevorach D: Systemic lupus erythematosus and apoptosis: A question of balance. Clin Rev Allergy Immunol 25: 49-60, 2003
5. Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE, Kalden JR, Herrmann M: Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 9: 173-187, 2006
6. Liu CC, Navratil JS, Sabatine JM, Ahearn JM: Apoptosis, complement and systemic lupus erythematosus: A mechanistic view. Curr Dir Autoimmun 7: 49-86, 2004
7. Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN: Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 91: 1687-1696, 1993
8. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK: Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 95: 531-541, 1995
9. Gleichmann E, Van Elven EH, Van der Veen JP: A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12: 152-159, 1982
10. Abbas AK: Disease of immunity. In: Robbins and Cotran Pathologic Basis of Disease, 7th Ed., edited by Kumar V, Abbas AK, Fausto N, Philadelphia, Saunders, 2005, pp 231
11. Alpers C: The Kidney. In: Robbins and Cotran Pathologic Basis of Disease, 7th Ed., edited by Kumar V, Abbas AK, Fausto N, Philadelphia, Saunders, 2005, pp 976-978
12. Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC: Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis. Clin Exp Immunol 110: 233-240, 1997
13. Lan HY, Nikolic-Paterson DJ, Atkins RC: Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab Invest 67: 743-751, 1992
14. Isome M, Fujinaka H, Adhikary LP, Kovalenko P, El-Shemi AG, Yoshida Y, Yaoita E, Takeishi T, Takeya M, Naito M, Suzuki H, Yamamoto T: Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats. Nephrol Dial Transplant 19: 2997-3004, 2004
15. Ka SM, Rifai A, Chen JH, Cheng CW, Shui HA, Lee HS, Lin YF, Hsu LF, Chen A: Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant 21: 288-298, 2006
16. Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood Wl, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396: 699-703, 1998
17. Zhang J, Salcedo TW, Wan X, Ullrich S, Hu B, Gregorio T, Feng P, Qi S, Chen H, Cho YH, Li Y, Moore PA, Wu J: Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest 107: 1459-1468, 2001
18. Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS: A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 274: 13733-13736, 1999
19. Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, Cho YH, Ullrich S, Kanakaraj P, Carrell J, Boyd E, Olsen HS, Hu G, Pukac L, Liu D, Ni J, Kim S, Gentz R, Feng P, Moore PA, Ruben SM, Wei P: TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492, 2002
20. Shi G, Wu Y, Zhang J, Wu J: Death decoy receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo. J Immunol 171: 3407-3414, 2003
21. Chang YC, Hsu TL, Lin HH, Chio CC, Chiu AW, Chen NJ, Lin CH, Hsieh SL: Modulation of macrophage differentiation and activation by decoy receptor 3. J Leukoc Biol 75: 486-494, 2004
22. Hsu TL, Chang YC, Chen SJ, Liu YJ, Chiu AW, Chio CC, Chen L, Hsieh SL: Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J Immunol 168: 4846-4853, 2002
23. Sung HH, Juang JH, Lin YC, Kuo CH, Hung JT, Chen A, Chang DM, Chang SY, Hsieh SL, Sytwu HK: Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J Exp Med 199: 1143-1151, 2004
24. Otsuki T, Tomokuni A, Sakaguchi H, Aikoh T, Matsuki T, Isozaki Y, Hyodoh F, Ueki H, Kusaka M, Kita S, Ueki A: Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. Clin Exp Immunol 119: 323-327, 2000
25. Van Elven EH, Rolink AG, Veen FV, Gleichmann E: Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease. J Exp Med 153: 1474-1488, 1981
26. Goldsby RA, Kindt TJ, Osborne BA, Kuby J: Cytokines. In: Immunology, 5th Ed., edited by Goldsby RA, New York, W.H. Freeman, 2003, pp 276-281
27. Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A: MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 58: 335-338, 2001
28. Wada T, Furuichi K, Segawa-Takaeda C, Shimizu M, Sakai N, Takeda SI, Takasawa K, Kida H, Kobayashi KI, Mukaida N, Ohmoto Y, Matsushima K, Yokoyama H: MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 56: 995-1003, 1999
29. Wong CK, Ho CY, Li EK, Lam CW: Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9: 589-593, 2000
30. Umland SP, Razac S, Nahrebne DK, Seymour BW: Effects of in vivo administration of interferon (IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease. Clin Immunol Immunopathol 63: 66-73, 1992
31. Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T, Fukuda K, Kanai H, Nakashima H, Otsuka T, Hirakata H: Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum 44: 2097-2106, 2001
32. Uhm WS, Na K, Song GW, Jung SS, Lee T, Park MH, Yoo DH: Cytokine balance in kidney tissue from lupus nephritis patients. Rheumatology (Oxford) 42: 935-938, 2003
33. Licht R, Dieker JW, Jacobs CW, Tax WJ, Berden JH: Decreased phagocytosis of apoptotic cells in diseased SLE mice. J Autoimmun 22: 139-145, 2004
34. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L: Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp Cell Res 226: 387-397, 1996
35. Huang XR, Tipping PG, Apostolopoulos J, Oettinger C, D'Souza M, Milton G, Holdsworth SR: Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol 109: 134-142, 1997
36. Lenda DM, Stanley ER, Kelley VR: Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. J Immunol 173: 4744-4754, 2004
37. Choudhury A, Maldonado MA, Cohen PL, Eisenberg RA: The role of host CD4 T cells in the pathogenesis of the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol 174: 7600-7609, 2005
38. Lang TJ, Nguyen P, Papadimitriou JC, Via CS: Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J Immunol 171: 5795-5801, 2003
39. Berden JH, Grootscholten C, Jurgen WC, van der Vlag J: Lupus nephritis: A nucleosome waste disposal defect? J Nephrol 15[Suppl 6]: S1-S10, 2002
40. Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F: Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 239: 121-128, 2006
41. Jeruc J, Vizjak A, Rozman B, Ferluga D: Immunohistochemical expression of activated caspase-3 as a marker of apoptosis in glomeruli of human lupus nephritis. Am J Kidney Dis 48: 410-418, 2006
42. Kamradt T, Mitchison NA: Tolerance and autoimmunity. N Engl J Med 344: 655-664, 2001
43. Kalled SL, Cutler AH, Burkly LC: Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment. J Immunol 167: 1740-1747, 2001
44. Seery JP, Cattell V, Watt FM: Cutting edge: Amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanylaspartyl-(beta-o-methyl)- fluoromethylketone. J Immunol 167: 2452-2455, 2001
45. Roth W, Isenmann S, Nakamura M, Platten M, Wick W, Kleihues P, Bahr M, Ohgaki H, Ashkenazi A, Weller M: Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res 61: 2759-2765, 2001
46. Liu F, Song Y, Liu D: Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258-1266, 1999
47. Chen A, Sheu LF, Ho YS, Lin YF, Chou WY, Chou TC, Lee WH: Experimental focal segmental glomerulosclerosis in mice. Nephron 78: 440-452, 1998
48. Chao TK, Rifai A, Ka SM, Yang SM, Shui HA, Lin YF, Sytwu HK, Lee WH, Kung JT, Chen A: The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy. Kidney Int 70: 283-297, 2006
49. Cheng CW, Rifai A, Ka SM, Shui HA, Lin YF, Lee WH, Chen A: Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. Kidney Int 68: 2694-2703, 2005
50. Assenmacher M, Schmitz J, Radbruch A: Flow cytometric determination of cytokines in activated murine T helper lymphocytes: Expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur J Immunol 24: 1097-1101, 1994